April 2, 2021
Takeda Pharmaceutical said on April 1 that it has completed the sale of some 130 OTC and non-core prescription drugs sold in Europe to Denmark’s Orifarm for US$670 million, along with two manufacturing sites in Denmark and Poland. The company...read more